FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for clonazepam submitted by Teva Pharmaceuticals USA, Inc., marking an updated regulatory action for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Panic Disorder

Drugs mentioned

• KLONOPIN (clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)